BIOMAT Database Logo BIOMAT Database Logo

Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure. 1974

R G Henderson, and R G Russell, and J G Ledingham, and R Smith, and D O Oliver, and R J Walton, and D G Small, and C Preston, and G T Warner

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009129 Muscle Tonus The state of activity or tension of a muscle beyond that related to its physical properties, that is, its active resistance to stretch. In skeletal muscle, tonus is dependent upon efferent innervation. (Stedman, 25th ed) Muscle Tension,Muscle Tightness,Muscular Tension,Tension, Muscle,Tension, Muscular,Tightness, Muscle,Tonus, Muscle
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D012080 Chronic Kidney Disease-Mineral and Bone Disorder Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders. Renal Osteodystrophy,Renal Rickets,Rickets, Renal,CKD-MBD,Osteodystrophy, Renal,Chronic Kidney Disease Mineral and Bone Disorder,Osteodystrophies, Renal,Renal Osteodystrophies
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone

Related Publications

R G Henderson, and R G Russell, and J G Ledingham, and R Smith, and D O Oliver, and R J Walton, and D G Small, and C Preston, and G T Warner
Short-term effects of 1,25-dihydroxycholecalciferol on disordered calcium metabolism of renal failure.
July 1974, The American journal of medicine,
R G Henderson, and R G Russell, and J G Ledingham, and R Smith, and D O Oliver, and R J Walton, and D G Small, and C Preston, and G T Warner
Failure of formation of 1,25-dihydroxycholecalciferol in chronic renal insufficiency.
March 1973, Lancet (London, England),
R G Henderson, and R G Russell, and J G Ledingham, and R Smith, and D O Oliver, and R J Walton, and D G Small, and C Preston, and G T Warner
Local action of oral 1,25-dihydroxycholecalciferol on calcium absorption in osteoporosis.
August 1987, The American journal of clinical nutrition,
R G Henderson, and R G Russell, and J G Ledingham, and R Smith, and D O Oliver, and R J Walton, and D G Small, and C Preston, and G T Warner
Effect of 1,25-dihydroxycholecalciferol on ethanol mediated suppression of calcium absorption.
July 1975, Calcified tissue research,
R G Henderson, and R G Russell, and J G Ledingham, and R Smith, and D O Oliver, and R J Walton, and D G Small, and C Preston, and G T Warner
Interrelation of cortisone and 1,25 dihydroxycholecalciferol on intestinal calcium and phosphate absorption.
September 1984, Calcified tissue international,
R G Henderson, and R G Russell, and J G Ledingham, and R Smith, and D O Oliver, and R J Walton, and D G Small, and C Preston, and G T Warner
Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol.
September 1978, Lancet (London, England),
R G Henderson, and R G Russell, and J G Ledingham, and R Smith, and D O Oliver, and R J Walton, and D G Small, and C Preston, and G T Warner
Long-term 1,25-dihydroxycholecalciferol treatment in renal failure.
January 1983, Acta medica Scandinavica,
R G Henderson, and R G Russell, and J G Ledingham, and R Smith, and D O Oliver, and R J Walton, and D G Small, and C Preston, and G T Warner
[Effects of 1,24 R-dihydroxycholecalciferol on the calcium metabolism and renal function in predialysis chronic renal failure].
April 1986, Nihon Jinzo Gakkai shi,
R G Henderson, and R G Russell, and J G Ledingham, and R Smith, and D O Oliver, and R J Walton, and D G Small, and C Preston, and G T Warner
Biochemical and histological effects of 1,25 dihydroxycholecalciferol (1,25-DHCC) in the osteomalacia of chronic and failure.
December 1974, Journal d'urologie et de nephrologie,
R G Henderson, and R G Russell, and J G Ledingham, and R Smith, and D O Oliver, and R J Walton, and D G Small, and C Preston, and G T Warner
Hypophosphatemia in long-term renal transplant recipients: effects on bone histology and 1,25-dihydroxycholecalciferol.
January 1986, Mineral and electrolyte metabolism,
Copied contents to your clipboard!